Observational studyJAMA network open2019

Comparative Survival Associated With Use of Targeted vs Nontargeted Therapy in Medicare Patients With Metastatic Renal Cell Carcinoma.

Pengxiang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.